Sosei Group Public
Sosei Group is a Japanese biopharmaceutical company that focuses on developing and commercializing innovative drugs. With a strong emphasis on research and development, the company aims to address various medical conditions such as Alzheimer's disease, schizophrenia, cancer, migraine, addiction, and metabolic disease. Sosei Group utilizes advanced technologies, including GPCR structure-based drug design, peptide platform technologies, and nanotechnology, to create a robust product pipeline with first-in-class potential. The company has already achieved significant success by bringing three medicines to the market, including two COPD bronchodilators and an emergency contraceptive, which generate stable revenue streams for further growth.
Funding Status:
IPO
Technology:
Others
Number Of Exists:
1
Investors Number:
7
Employee Number:
ноя 50
Last Funding Date:
16 07 20
Industry:
PharmTech
Headquarters:
Tokyo, Tokyo, Japan
Total Funding:
265028950
Last Funding Type:
Post-IPO Debt
Founded Date:
01 06 90
Acquisitions Number:
2
Investor Type:
For Profit